Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor Microenvironment

被引:98
作者
Scott, Ellen N. [1 ,2 ,3 ]
Gocher, Angela M. [1 ,2 ]
Workman, Creg J. [1 ,2 ]
Vignali, Dario A. A. [1 ,2 ,3 ,4 ]
机构
[1] Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh Med Ctr UPMC, Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Grad Program Microbiol & Immunol, Sch Med, Pittsburgh, PA USA
[4] UPMC Hillman Canc Ctr, Canc Immunol & Immunotherapy Program, Pittsburgh, PA 15232 USA
来源
FRONTIERS IN IMMUNOLOGY | 2021年 / 12卷
基金
美国国家卫生研究院;
关键词
regulatory T cells (Treg); immune infiltration; tumor microenvironment; cancer; vasculature; stroma; ENDOTHELIAL GROWTH-FACTOR; CANCER-ASSOCIATED FIBROBLASTS; FOLLICULAR LYMPHOMA; RECEPTOR REPERTOIRE; PROGNOSTIC VALUE; DENDRITIC CELLS; BREAST-CANCER; HIGH NUMBERS; PROMOTES; IMMUNOTHERAPY;
D O I
10.3389/fimmu.2021.702726
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Regulatory T cells (T-regs) are key immunosuppressive cells that promote tumor growth by hindering the effector immune response. T-regs utilize multiple suppressive mechanisms to inhibit pro-inflammatory responses within the tumor microenvironment (TME) by inhibition of effector function and immune cell migration, secretion of inhibitory cytokines, metabolic disruption and promotion of metastasis. In turn, T-regs are being targeted in the clinic either alone or in combination with other immunotherapies, in efforts to overcome the immunosuppressive TME and increase anti-tumor effects. However, it is now appreciated that T-regs not only suppress cells intratumorally via direct engagement, but also serve as key interactors in the peritumor, stroma, vasculature and lymphatics to limit anti-tumor immune responses prior to tumor infiltration. We will review the suppressive mechanisms that T-regs utilize to alter immune and non-immune cells outside and within the TME and discuss how these mechanisms collectively allow T-regs to create and promote a physical and biological barrier, resulting in an immune-excluded or limited tumor microenvironment.
引用
收藏
页数:10
相关论文
共 124 条
  • [1] Regulatory T cells: recommendations to simplify the nomenclature
    Abbas, Abul K.
    Benoist, Christophe
    Bluestone, Jeffrey A.
    Campbell, Daniel J.
    Ghosh, Sankar
    Hori, Shohei
    Jiang, Shuiping
    Kuchroo, Vijay K.
    Mathis, Diane
    Roncarolo, Maria Grazia
    Rudensky, Alexander
    Sakaguchi, Shimon
    Shevach, Ethan M.
    Vignali, Dario A. A.
    Ziegler, Steve F.
    [J]. NATURE IMMUNOLOGY, 2013, 14 (04) : 307 - 308
  • [2] Tumor-infiltrating human CD4+ regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity
    Ahmadzadeh, Mojgan
    Pasetto, Anna
    Jia, Li
    Deniger, Drew C.
    Stevanovic, Sanja
    Robbins, Paul F.
    Rosenberg, Steven A.
    [J]. SCIENCE IMMUNOLOGY, 2019, 4 (31)
  • [3] Mechanisms of interleukin-10-mediated immune suppression
    Akdis, CA
    Blaser, K
    [J]. IMMUNOLOGY, 2001, 103 (02) : 131 - 136
  • [4] Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments
    Angelin, Alessia
    Gil-de-Gomez, Luis
    Dahiya, Satinder
    Jiao, Jing
    Guo, Lili
    Levine, Matthew H.
    Wang, Zhonglin
    Quinn, William J., III
    Kopinski, Piotr K.
    Wang, Liqing
    Akimova, Tatiana
    Liu, Yujie
    Bhatti, Tricia R.
    Han, Rongxiang
    Laskin, Benjamin L.
    Baur, Joseph A.
    Blair, Ian A.
    Wallace, Douglas C.
    Hancock, Wayne W.
    Beier, Ulf H.
    [J]. CELL METABOLISM, 2017, 25 (06) : 1282 - +
  • [5] CTLA-4/CD80 pathway regulates T cell infiltration into pancreatic cancer
    Bengsch, Fee
    Knoblock, Dawson M.
    Liu, Anni
    McAllister, Florencia
    Beatty, Gregory L.
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (12) : 1609 - 1617
  • [6] Foxp3+ T Cells Induce Perforin-Dependent Dendritic Cell Death in Tumor-Draining Lymph Nodes
    Boissonnas, Alexandre
    Scholer-Dahirel, Alix
    Simon-Blancal, Virginie
    Pace, Luigia
    Valet, Fabien
    Kissenpfennig, Adrien
    Sparwasser, Tim
    Malissen, Bernard
    Fetler, Luc
    Amigorena, Sebastian
    [J]. IMMUNITY, 2010, 32 (02) : 266 - 278
  • [7] Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy
    Bos, Paula D.
    Plitas, George
    Rudra, Dipayan
    Lee, Sue Y.
    Rudensky, Alexander Y.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 210 (11) : 2435 - 2446
  • [8] Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy
    Bowyer, S.
    Prithviraj, P.
    Lorigan, P.
    Larkin, J.
    McArthur, G.
    Atkinson, V.
    Millward, M.
    Khou, M.
    Diem, S.
    Ramanujam, S.
    Kong, B.
    Liniker, E.
    Guminski, A.
    Parente, P.
    Andrews, M. C.
    Parakh, S.
    Cebon, J.
    Long, G. V.
    Carlino, M. S.
    Klein, O.
    [J]. BRITISH JOURNAL OF CANCER, 2016, 114 (10) : 1084 - 1089
  • [9] Bruno TC, 2020, NATURE, V577, DOI 10.1038/d41586-019-03943-0
  • [10] Convergences and divergences of tnymus- and peripherally derived regulatory T cells in cancer
    Burocchi, Alessia
    Colombo, Mario P.
    Piconese, Silvia
    [J]. FRONTIERS IN IMMUNOLOGY, 2013, 4